TAD
TAD integrates clinical and molecular data from prostate cancer tissue microarrays to enable biomarker correlation, multivariable predictive modeling, and analysis of molecular heterogeneity.
Key Features:
- Integration of Clinical and Molecular Data: Links immunohistochemical data from tissue microarrays (TMAs) with patient-specific clinical information to contextualize prostate cancer biomarkers.
- Automated Data Management: Uses a relational SQL database to automate the recording and association of scoring data with clinical datasets.
- Automated Scoring: Implements automated recording of scores to ensure consistent data capture across large numbers of TMA cores.
- Biomarker Correlation Analysis: Analyzes expression levels of proteins implicated in prostate cancer pathogenesis, including bax, bcl-2, bin1, CD95 (FAS), mdm2, p21, p53, and NFkappaB, to identify associations with disease virulence.
- Support for Multivariable Analysis: Supports multivariable logistic regression methods for predictive modeling of biological potential, with specific application to Gleason score 7 prostate cancer.
- TMA Composition: Incorporates a 255-core prostate cancer TMA constructed from 47 prostatectomy specimens, including cores from transition and peripheral zone origins and replicate cores for Gleason grades 5–9.
- Analysis of Molecular Heterogeneity: Enables comparison of molecular differences among Gleason scores, including heterogeneity within Gleason grade 3 prostatectomy specimens.
Scientific Applications:
- Prostate Cancer Biomarker Research: Defines biomarker correlates of prostate cancer virulence to inform therapeutic decision-making for early-stage disease.
- Risk Stratification: Supports stratification of patients with tumors of uncertain prognosis by linking molecular profiles to Gleason grades and clinical outcomes.
- Investigation of Gleason 7 Biology: Facilitates predictive modeling and biological interpretation specifically for Gleason score 7 prostate cancers.
Methodology:
Relational SQL database storage and automated recording of TMA scores, automated scoring workflows, and multivariable logistic regression for predictive analysis.
Topics
Details
- Tool Type:
- desktop application
- Operating Systems:
- Windows
- Added:
- 12/18/2017
- Last Updated:
- 11/25/2024
Operations
Publications
McDonnell TJ, Chari NS, Cho-Vega JH, Troncoso P, Wang X, Bueso-Ramos CE, Coombes K, Brisbay S, Lopez R, Prendergast G, Logothetis C, Do K. Biomarker expression patterns that correlate with high grade features in treatment naive, organ-confined prostate cancer. BMC Medical Genomics. 2008;1(1). doi:10.1186/1755-8794-1-1. PMID:18237448. PMCID:PMC2227949.